(Q44348717)

2 December 2017

title

Chronic naltrexone differentially affects supraspinal delta-opioid receptor-mediated antinociception (English)

1 reference

2 December 2017

0 references

Kest B

1

1 reference

2 December 2017

Lee CE

2

1 reference

2 December 2017

Jenab S

3

1 reference

2 December 2017

Kao B

4

1 reference

2 December 2017

Inturrisi CE

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

European Journal of Pharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

345

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

47-53

1 reference

Effects of chronic administration of 7-benzylidene-7-dehydronaltrexone and naltriben on the antinociceptive actions of delta 1- and delta 2-opioid receptor agonists

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Naltrexone induces down- and upregulation of delta opioid receptors in rat brain regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Kappa 3 opiate receptor binding in the mouse and rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Chronic d-amphetamine inhibits opioid receptor antagonist-induced supersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Assessment of delta opioid antinociception and receptor mRNA levels in mouse after chronic naltrexone treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Streptozotocin-induced diabetes selectively enhances antinociception mediated by delta 1- but not delta 2-opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Blockade of morphine supersensitivity by an antisense oligodeoxynucleotide targeting the delta opioid receptor (DOR-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Lack of antinociceptive efficacy of intracerebroventricular [D-Ala2,Glu4]deltorphin, but not [D-Pen2,D-Pen5]enkephalin, in the mu-opioid receptor deficient CXBK mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Delta-opioid supraspinal antinociception in mice is mediated by Gi3 transducer proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

The effect of naltrindole on spinal and supraspinal delta opioid receptors and analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Agonist and antagonist activities of ligands derived from naltrexone and oxymorphone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Modification of the response to opioid and monopioid drugs by chronic opioid antagonist treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Upregulation of opioid receptor subtypes correlates with potency changes of morphine and DADLE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Chronic opioid antagonist treatment increases mu and delta receptor mediated spinal opioid analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

Naltrexone-induced opiate receptor supersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901584-7

10.1016/S0014-2999(97)01584-7

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference